300 related articles for article (PubMed ID: 15024054)
1. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway.
Kataoka T; Tschopp J
Mol Cell Biol; 2004 Apr; 24(7):2627-36. PubMed ID: 15024054
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal domain of the long form of cellular FLICE-inhibitory protein (c-FLIPL) inhibits the interaction of the caspase 8 prodomain with the receptor-interacting protein 1 (RIP1) death domain and regulates caspase 8-dependent nuclear factor κB (NF-κB) activation.
Matsuda I; Matsuo K; Matsushita Y; Haruna Y; Niwa M; Kataoka T
J Biol Chem; 2014 Feb; 289(7):3876-87. PubMed ID: 24398693
[TBL] [Abstract][Full Text] [Related]
3. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation.
Dohrman A; Kataoka T; Cuenin S; Russell JQ; Tschopp J; Budd RC
J Immunol; 2005 May; 174(9):5270-8. PubMed ID: 15843523
[TBL] [Abstract][Full Text] [Related]
4. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
Micheau O; Thome M; Schneider P; Holler N; Tschopp J; Nicholson DW; Briand C; Grütter MG
J Biol Chem; 2002 Nov; 277(47):45162-71. PubMed ID: 12215447
[TBL] [Abstract][Full Text] [Related]
5. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
Kataoka T; Budd RC; Holler N; Thome M; Martinon F; Irmler M; Burns K; Hahne M; Kennedy N; Kovacsovics M; Tschopp J
Curr Biol; 2000 Jun; 10(11):640-8. PubMed ID: 10837247
[TBL] [Abstract][Full Text] [Related]
6. Activation of NF-kappaB by FADD, Casper, and caspase-8.
Hu WH; Johnson H; Shu HB
J Biol Chem; 2000 Apr; 275(15):10838-44. PubMed ID: 10753878
[TBL] [Abstract][Full Text] [Related]
7. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex.
Krueger A; Schmitz I; Baumann S; Krammer PH; Kirchhoff S
J Biol Chem; 2001 Jun; 276(23):20633-40. PubMed ID: 11279218
[TBL] [Abstract][Full Text] [Related]
8. The SCF
Roberts JZ; Holohan C; Sessler T; Fox J; Crawford N; Riley JS; Khawaja H; Majkut J; Evergren E; Humphreys LM; Ferris J; Higgins C; Espona-Fiedler M; Moynagh P; McDade SS; Longley DB
Cell Death Differ; 2020 Sep; 27(9):2726-2741. PubMed ID: 32313199
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
[TBL] [Abstract][Full Text] [Related]
10. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression.
Lüschen S; Ussat S; Scherer G; Kabelitz D; Adam-Klages S
J Biol Chem; 2000 Aug; 275(32):24670-8. PubMed ID: 10827087
[TBL] [Abstract][Full Text] [Related]
11. Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases.
Harper N; Farrow SN; Kaptein A; Cohen GM; MacFarlane M
J Biol Chem; 2001 Sep; 276(37):34743-52. PubMed ID: 11461927
[TBL] [Abstract][Full Text] [Related]
12. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
Xiao CW; Yan X; Li Y; Reddy SA; Tsang BK
Endocrinology; 2003 Feb; 144(2):623-30. PubMed ID: 12538625
[TBL] [Abstract][Full Text] [Related]
13. The c-FLIPL cleavage product p43FLIP promotes activation of extracellular signal-regulated kinase (ERK), nuclear factor κB (NF-κB), and caspase-8 and T cell survival.
Koenig A; Buskiewicz IA; Fortner KA; Russell JQ; Asaoka T; He YW; Hakem R; Eriksson JE; Budd RC
J Biol Chem; 2014 Jan; 289(2):1183-91. PubMed ID: 24275659
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of caspase-8/FLICE processing and activation upon Fas stimulation with novel antibodies directed against a cleavage site for caspase-8 and its substrate, FLICE-like inhibitory protein (FLIP).
Niikura Y; Nonaka T; Imajoh-Ohmi S
J Biochem; 2002 Jul; 132(1):53-62. PubMed ID: 12097160
[TBL] [Abstract][Full Text] [Related]
15. In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.
Moujalled DM; Cook WD; Lluis JM; Khan NR; Ahmed AU; Callus BA; Vaux DL
Cell Death Differ; 2012 May; 19(5):808-15. PubMed ID: 22095280
[TBL] [Abstract][Full Text] [Related]
16. Activation of the NF-kappaB pathway by caspase 8 and its homologs.
Chaudhary PM; Eby MT; Jasmin A; Kumar A; Liu L; Hood L
Oncogene; 2000 Sep; 19(39):4451-60. PubMed ID: 11002417
[TBL] [Abstract][Full Text] [Related]
17. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
Harper N; Hughes M; MacFarlane M; Cohen GM
J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
[TBL] [Abstract][Full Text] [Related]
19. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation.
Misra RS; Russell JQ; Koenig A; Hinshaw-Makepeace JA; Wen R; Wang D; Huo H; Littman DR; Ferch U; Ruland J; Thome M; Budd RC
J Biol Chem; 2007 Jul; 282(27):19365-74. PubMed ID: 17462996
[TBL] [Abstract][Full Text] [Related]
20. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.
Golks A; Brenner D; Krammer PH; Lavrik IN
J Exp Med; 2006 May; 203(5):1295-305. PubMed ID: 16682493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
